Latest News of BMEA
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
A list of top biotech penny stocks includes Biomea Fusion, Inc. (NASDAQ:BMEA), a company developing treatments for cancers and metabolic diseases. Despite setbacks, BMEA shows potential for growth wit...
Why Are Hedge Funds Shorting Biomea Fusion, Inc. (BMEA)?
Short selling is when assets are borrowed and sold to profit from price declines. Hedge funds often engage in short selling to protect their interests. Despite risks, short selling benefits market eff...
Biomea Fusion, Inc. (NASDAQ:BMEA) Downgraded by Barclays
Analysts lowered ratings for various stocks, including Biomea Fusion, Inc. due to FDA's clinical hold on BMF-219 trials. Despite setbacks, some analysts remain optimistic about the company's long-term...